Lv11
36 积分 2023-10-26 加入
Design, Synthesis, and Biological Evaluation of Novel Diaminopyrimidine Macrocycles as Fourth Generation Reversible EGFR Inhibitors That Overcome Clinical Resistance to Osimertinib Mediated by C797S Mutation
4小时前
已完结
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation
5小时前
已完结
Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells
10天前
已完结
Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy
10天前
已完结
Therapy with oncolytic viruses: progress and challenges
23天前
已完结
HDAC11 Inhibition as a Potential Therapeutic Strategy for AML: Target Identification, Lead Discovery, Antitumor Potency, and Mechanism Investigation
25天前
已完结
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases
29天前
已完结
Discovery of Novel Imidazo[1,2-a]pyridine-Based HDAC6 Inhibitors as an Anticarcinogen with a Cardioprotective Effect
1个月前
已完结
Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity
1个月前
已完结
Indolo[3,2-c]isoquinoline Hydroxamic Acid Derivatives as Novel Orally Topoisomerase-Histone Deacetylase Dual Inhibitors for NSCLC Therapy
1个月前
已完结
皖公网安备34019202002308
